InvestorsHub Logo
Followers 46
Posts 6269
Boards Moderated 0
Alias Born 06/17/2009

Re: None

Wednesday, 12/29/2021 7:02:00 AM

Wednesday, December 29, 2021 7:02:00 AM

Post# of 1125
NRx Pharmaceuticals Files Breakthrough Therapy Designation Request for ZYESAMI® (aviptadil) in Patients at Immediate Risk of Death from COVID-19 Despite Treatment with Remdesivir and Other Approved Therapies

https://ir.nrxpharma.com/news-events/press-releases/detail/105/nrx-pharmaceuticals-files-breakthrough-therapy-designation

Might be a positive day.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NRXP News